Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 25, 2020
Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathyIzabella Z A Pawluczyk, Maria S F Soares, William A Barratt, et al.
Kidney International|May 29, 2020
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction ToolSean J Barbour, Mark Canney, Rosanna Coppo, et al.
Journal of the American Society of Nephrology : JASN|February 18, 2017
Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1Daniel P Gale, Karen Molyneux, David Wimbury, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled TrialJonathan Barratt, Adrian Liew, See Cheng Yeo, et al.
The New England Journal of Medicine|October 25, 2024
Alternative Complement Pathway Inhibition with Iptacopan in IgA NephropathyVlado Perkovic, Jonathan Barratt, Brad Rovin, et al.
Kidney International Reports|January 15, 2025
Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA NephropathyHiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International Reports|April 30, 2025
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226]Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Kidney International|January 22, 2026
Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+β7+ cells in IgA nephropathyXingzi Liu, Lan Wang, Miaomiao Lin, et al.
Archives of Disease in Childhood|October 8, 2024
National recommendations for the management of children and young people with IgA vasculitis: a best available evidence, group agreement-based approachLouise Oni, Caroline Platt, Matko Marlais, et al.
Pageof 23